×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 7 - Regulatory Update
Session Chair(s)
Joerg Windisch, PhD
Chief Science Officer
Sandoz Biopharmaceuticals, Austria
Speaker(s)
Panel Discussion
Leah Christl, PhD
Amgen, United States
Exec Director, Global Biosimilars Regulatory Affairs & Regulatory & R&D Policy
Cathy A. Parker
Health Canada, Canada
Director General, Biologics & Genetic Therapies Directorate HPFB
Jian Wang, MD, PhD
Health Canada, Canada
Division Manager, Clinical Review Division – Heamatology/Oncology
Niklas Ekman
Finnish Medicines Agency, Finland
Senior Researcher
Have an account?